Helix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Helix and buy or sell other stocks, ETFs, and their options commission-free!About HLXA
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
CEOJorge Santos da Silva, PhD
CEOJorge Santos da Silva, PhD
Employees100
Employees100
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2021
Founded2021
Employees100
Employees100
HLXA Key Statistics
Market cap844.09M
Market cap844.09M
Price-Earnings ratio-4.12
Price-Earnings ratio-4.12
Dividend yield—
Dividend yield—
Average volume1.25M
Average volume1.25M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$62.75
52 Week high$62.75
52 Week low$5.95
52 Week low$5.95
Stock Snapshot
The current Helix(HLXA) stock price is $13.25, with a market capitalization of 844.09M. The stock trades at a price-to-earnings (P/E) ratio of -4.12.
Helix(HLXA) stock opened on 2025-12-30 at —. The price climbed to — and dipped to —.
Helix(HLXA) shares are trading with a volume of 0, against a daily average of 1.25M.
In the last year, Helix(HLXA) shares hit a 52-week high of $62.75 and a 52-week low of $5.95.
In the last year, Helix(HLXA) shares hit a 52-week high of $62.75 and a 52-week low of $5.95.
People also own
Based on the portfolios of people who own HLXA. This list is generated using Robinhood data, and it’s not a recommendation.